GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | 8/7/2026 8:37:33 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $660,601 +12.0% | Assets $6,967,998 | EPS -$0.41 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/6/2026 4:52:04 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $660,601 +12.0% | Assets $6,967,998 | EPS -$0.41 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/13/2026 8:06:35 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $806,923 +36.0% | Assets $7,908,991 | EPS -$0.20 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 5/12/2026 4:42:20 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $806,923 +36.0% | Assets $7,908,991 | EPS -$0.20 | |
| Xenetic Biosciences, Inc. (XBIO) | 4/24/2026 5:21:56 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,976,411 +19.0% | Assets $8,363,847 | EPS -$1.58 | |
| Xenetic Biosciences, Inc. (XBIO) | 3/13/2026 8:01:41 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $766,296 +18.1% | Assets $8,363,847 | EPS -$0.22 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/12/2026 5:16:27 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,976,411 +19.0% | Assets $8,363,847 | EPS -$1.58 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/13/2025 8:46:50 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,026,957 +67.2% | Assets $5,067,960 | EPS -$0.33 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/12/2025 4:43:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,026,957 +67.2% | Assets $5,067,960 | EPS -$0.33 | |
| Xenetic Biosciences, Inc. (XBIO) | 10/31/2025 4:11:54 PM | View | Proxy | SEC | Y 2024 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/13/2025 8:02:04 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $589,897 -18.8% | Assets $5,353,700 | EPS -$0.45 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/12/2025 5:15:30 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $589,897 -18.8% | Assets $5,353,700 | EPS -$0.45 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/14/2025 8:28:40 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $593,261 +16.1% | Assets $5,791,217 | EPS -$0.59 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 5/13/2025 5:15:06 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $593,261 +16.1% | Assets $5,791,217 | EPS -$0.59 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/13/2025 4:44:29 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $2,500,284 -1.6% | Assets $6,901,443 | EPS -$2.57 | |
| Xenetic Biosciences, Inc. (XBIO) | 4/29/2025 5:13:28 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $2,500,284 -1.6% | Assets $6,901,443 | EPS -$2.57 | |
| Xenetic Biosciences, Inc. (XBIO) | 3/19/2025 8:06:21 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $648,820 -3.4% | Assets $6,901,443 | EPS -$0.68 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/18/2025 4:43:31 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $2,500,284 -1.6% | Assets $6,901,443 | EPS -$2.57 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/13/2024 8:32:25 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $614,243 +0.5% | Assets $8,046,000 | EPS -$0.28 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/12/2024 4:45:09 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $614,243 +0.5% | Assets $8,046,000 | EPS -$0.28 | |
| Xenetic Biosciences, Inc. (XBIO) | 10/31/2024 4:31:13 PM | View | Proxy | SEC | Y 2023 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/14/2024 8:01:05 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $726,404 +11.6% | Assets $9,033,330 | EPS -$0.83 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/13/2024 4:50:03 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $726,404 +11.6% | Assets $9,033,330 | EPS -$0.83 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/10/2024 8:31:21 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $510,817 -15.7% | Assets $9,394,096 | EPS -$0.78 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 5/9/2024 5:17:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $510,817 -15.7% | Assets $9,394,096 | EPS -$0.78 | |
| Xenetic Biosciences, Inc. (XBIO) | 3/22/2024 8:01:05 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $671,963 +38.0% | Assets $10,605,226 | EPS -$0.77 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/21/2024 5:16:12 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $2,539,986 +48.8% | Assets $10,605,226 | EPS -$2.71 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/13/2023 5:01:25 PM | View | Proxy | SEC | Y 2022 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 11/13/2023 8:47:14 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $611,174 +47.5% | Assets $11,961,066 | EPS -$0.69 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/9/2023 5:17:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $611,174 +47.5% | Assets $11,961,066 | EPS -$0.69 | |
| Xenetic Biosciences, Inc. (XBIO) | 8/11/2023 8:06:36 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $651,005 +56.2% | Assets $12,749,173 | EPS -$0.69 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/10/2023 4:48:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $651,005 +56.2% | Assets $12,749,173 | EPS -$0.69 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/11/2023 4:43:37 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $605,844 +55.7% | Assets $13,715,797 | EPS -$0.06 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/11/2023 4:32:56 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $605,844 +55.7% | Assets $13,715,797 | EPS -$0.06 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/23/2023 7:30:51 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $486,972 +46.4% | Assets $14,720,290 | EPS -$0.10 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/22/2023 4:37:48 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $1,706,925 +47.1% | Assets $14,720,290 | EPS -$0.46 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/10/2022 7:07:45 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $414,250 +18.6% | Assets $15,573,126 | EPS -$0.06 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/9/2022 4:45:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $414,250 +18.6% | Assets $15,573,126 | EPS -$0.06 | |
| Xenetic Biosciences, Inc. (XBIO) | 10/17/2022 5:01:51 PM | View | Proxy | SEC | Y 2021 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/12/2022 8:02:03 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $416,710 +44.9% | Assets $16,468,104 | EPS -$0.19 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/11/2022 5:16:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $416,710 +44.9% | Assets $16,468,104 | EPS -$0.19 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/12/2022 4:18:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $388,993 +103.4% | Assets $17,983,509 | ||
| Xenetic Biosciences, Inc. (XBIO) | 3/23/2022 8:31:39 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $332,604 +119.8% | Assets $19,815,360 | EPS -$0.14 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/22/2022 5:43:57 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $1,160,692 +165.6% | Assets $19,815,360 | EPS -$0.55 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/12/2021 8:01:33 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $349,269 +201.3% | Assets $21,285,402 | EPS -$0.13 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/12/2021 7:55:29 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $349,269 +201.3% | Assets $21,285,402 | EPS -$0.13 | |
| Xenetic Biosciences, Inc. (XBIO) | 10/15/2021 5:01:21 PM | View | Proxy | SEC | Y 2020 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/13/2021 8:07:06 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $287,603 +154.7% | Assets $10,915,278 | EPS -$0.13 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/12/2021 4:44:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $287,603 +154.7% | Assets $10,915,278 | EPS -$0.13 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/12/2021 7:01:05 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $191,216 +237.0% | Assets $11,761,622 | Export Earnings Model | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/11/2021 5:14:53 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $191,216 +237.0% | Assets $11,761,622 | ||
| Xenetic Biosciences, Inc. (XBIO) | 3/17/2021 8:01:26 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $151,332 +786.7% | Assets $13,179,495 | EPS -$0.15 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/16/2021 5:26:01 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $436,942 +2,460.3% | Assets $13,179,495 | EPS -$1.70 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/13/2020 8:01:31 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $115,934 | Assets $8,696,414 | EPS -$1.20 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/12/2020 5:22:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $115,934 | Assets $8,696,414 | EPS -$1.20 | |
| Xenetic Biosciences, Inc. (XBIO) | 10/13/2020 4:31:01 PM | View | Proxy | SEC | Y 2019 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/13/2020 7:06:37 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $112,927 | Assets $19,063,358 | EPS -$0.15 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/12/2020 4:44:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $112,927 | Assets $19,063,358 | EPS -$0.15 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/14/2020 4:15:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $56,749 | Assets $20,625,239 | EPS -$0.19 | |
| Xenetic Biosciences, Inc. (XBIO) | 5/14/2020 4:06:34 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $56,749 | Assets $20,625,239 | EPS -$0.19 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/27/2020 9:01:36 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $17,066 | Assets $21,546,926 | EPS $2.74 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 3/26/2020 5:22:54 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $17,066 | Assets $21,546,926 | EPS -$6.33 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/15/2019 8:31:48 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $0 | Assets $22,875,119 | EPS -$2.67 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/14/2019 5:47:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $22,875,119 | EPS -$2.67 | ||
| Xenetic Biosciences, Inc. (XBIO) | 11/8/2019 4:32:55 PM | View | Proxy | SEC | Y 2018 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/15/2019 7:36:52 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $0 | Assets $15,633,194 | EPS -$1.56 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/14/2019 5:30:31 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $15,633,194 | EPS -$1.56 | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/13/2019 8:03:05 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $0 | Assets $16,456,192 | EPS -$6.45 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 5/13/2019 6:14:53 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $16,456,192 | EPS -$6.45 | ||
| Xenetic Biosciences, Inc. (XBIO) | 3/29/2019 5:18:13 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $14,431,094 | EPS -$9.66 | ||
| Xenetic Biosciences, Inc. (XBIO) | 11/13/2018 5:14:23 PM | View | Proxy | SEC | Y 2017 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 11/9/2018 4:45:22 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $59 -99.9% | Assets $15,533,702 | EPS -$2.31 | |
| Xenetic Biosciences, Inc. (XBIO) | 8/10/2018 4:41:26 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $17,257,178 | EPS -$2.78 | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/15/2018 6:31:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $427 | Assets $17,543,005 | EPS -$2.51 | |
| Xenetic Biosciences, Inc. (XBIO) | 3/30/2018 4:36:12 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $7,585,000 +152.8% | Assets $19,163,643 | EPS -$4.98 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/15/2017 7:06:26 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $85,000 | Assets $14,639,645 | EPS -$0.26 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 11/14/2017 4:55:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $85,000 | Assets $14,639,645 | EPS -$0.26 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/3/2017 8:00:59 AM | View | Proxy | SEC | Y 2016 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 8/15/2017 8:05:09 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $9,745 | Assets $16,438,469 | EPS -$0.34 | Export Earnings Model | |
| Xenetic Biosciences, Inc. (XBIO) | 8/14/2017 5:26:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $9,745 | Assets $16,438,469 | EPS -$0.34 | |
| Xenetic Biosciences, Inc. (XBIO) | 6/22/2017 5:05:31 PM | View | Proxy | SEC | Y 2016 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 5/15/2017 6:05:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $18,831,518 | EPS -$0.34 | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/2/2017 3:41:01 PM | View | Proxy | SEC | Y 2016 | ||||||
| Xenetic Biosciences, Inc. (XBIO) | 3/31/2017 5:07:47 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $3,000,000 | Assets $20,973,865 | EPS -$7.84 | |
| Xenetic Biosciences, Inc. (XBIO) | 11/14/2016 5:23:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $13,866,047 | EPS -$0.28 | ||
| Xenetic Biosciences, Inc. (XBIO) | 8/15/2016 4:59:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $13,160,711 | EPS -$6.12 | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/16/2016 5:22:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $18,360,078 | EPS -$0.78 | ||
| Xenetic Biosciences, Inc. (XBIO) | 3/30/2016 3:19:10 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $16,908,388 | EPS -$2.96 | ||
| Xenetic Biosciences, Inc. (XBIO) | 11/16/2015 4:27:16 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $14,253,845 | EPS -$1.26 | ||
| Xenetic Biosciences, Inc. (XBIO) | 8/19/2015 3:39:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $13,269,724 | EPS -$0.27 | ||
| Xenetic Biosciences, Inc. (XBIO) | 7/20/2015 1:42:09 PM | Micro | View | Financials | 10-K/A | SEC | Y 2013 ending: 12/31/2013 | Rev: $96,900 -14.1% | Assets $486,809 | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/20/2015 5:26:17 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $14,041,475 | EPS -$0.58 | ||
| Xenetic Biosciences, Inc. (XBIO) | 4/15/2015 4:50:09 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $16,316,146 | EPS -$0.11 | ||
| Xenetic Biosciences, Inc. (XBIO) | 11/14/2014 4:10:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $19,317,805 | EPS -$0.02 | ||
| Xenetic Biosciences, Inc. (XBIO) | 8/14/2014 5:02:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $23,052,552 | EPS -$0.02 | ||
| Xenetic Biosciences, Inc. (XBIO) | 5/20/2014 4:34:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $25,868,351 | EPS -$0.03 | ||
| Xenetic Biosciences, Inc. (XBIO) | 4/30/2014 5:13:49 PM | Micro | View | Financials | 10-K/A | SEC | Y 2013 ending: 12/31/2013 | Rev: $96,900 -14.1% | Assets $486,809 | ||
| General Sales & Leasing, Inc. (XBIO) | 1/10/2014 5:12:54 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 11/30/2013 | Assets $25,868,351 | EPS -$0.03 | ||
| General Sales & Leasing, Inc. (XBIO) | 11/27/2013 4:15:49 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 8/31/2013 | Rev: $96,900 -14.1% | Assets $486,809 | ||
| General Sales & Leasing, Inc. (XBIO) | 7/17/2013 12:49:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 5/31/2013 | Rev: $39,415 +8.2% | Assets $277,431 | ||
| General Sales & Leasing, Inc. (XBIO) | 4/22/2013 4:39:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 2/28/2013 | Rev: $32,560 -9.5% | Assets $270,738 | ||
| GENERAL AIRCRAFT INC. (XBIO) | 1/22/2013 5:31:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 11/30/2012 | Rev: $32,964 +139.8% | Assets $351,783 | EPS $0.00 | |
| GENERAL AIRCRAFT INC. (XBIO) | 12/14/2012 12:47:04 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 8/31/2012 | Rev: $112,786 | Assets $324,132 | EPS -$0.01 | |
| GENERAL AIRCRAFT INC. (XBIO) | 7/16/2012 3:00:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 5/31/2012 | ||||
| GENERAL AIRCRAFT INC. (XBIO) | 4/24/2012 2:56:18 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 2/29/2012 |